Iterum Therapeutics plc ( ITRMF) - Key Metrics
Stock symbol ITRMF is outdated, potentially delisted? Maybe it is available on other exchange?
ITRMF Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2025Q3 | $0.01 | -$0.20 | -$0.17 | -$0.17 |
| 2025Q2 | $0 | -$0.16 | -$0.12 | -$0.12 |
| 2025Q1 | $0 | -$0.14 | -$0.09 | -$0.09 |
| 2024Q4 | $0 | -$0.33 | -$0.22 | -$0.22 |
| 2024Q3 | $0 | -$0.30 | -$0.13 | -$0.13 |
ITRMF Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2025Q3 | 0% | -0.84 |
| 2025Q2 | 0% | -1.55 |
| 2025Q1 | 0% | -2.20 |
| 2024Q4 | 0% | -1.77 |
| 2024Q3 | 0% | -0.91 |
ITRMF
Price: $0.03
52 week price:
Earnings Per Share: -0.34 USD
Exchange: PNK
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 2.7 million